CL Takes SXSW - Day 5
Healthy food, ride-sharing for good and trade-free chocolate
CL Takes SXSW - Day 4
Science of Metrics, Housing for Better Health and Innovation in Pursuit for the Unexpected
CL Takes SXSW - Day 3
Art of Negotiation, Product Development, Lessons from Retail Marketing and Mass Meditation
CL Takes SXSW - Day 2
Emotional vs Rational Marketing, Open Source Technology, Improving Culture at Work
CL Takes SXSW - Day 1
First dose of AI, Machine Learning + Power of Human Interaction
SXSW - The Week Ahead
Follow along with the closerlook team as we take on SXSW 2019
Using Social Media To Hear The Concerns Of Patients
James Gillespie, Center for Healthcare Innovation, and David Ormesher, closerlook, inc. discuss how social media can be leveraged to address the concerns of patients.
We are in the hope business
We need to clearly and compassionately tell the patient story in all of its frustration, confusion, anger, and faith. Its grit. Hope.
Cannes Lions Festival: Celebrating Creativity Technology and the Ultimate Challenge
Cannes is a great place to get a sense for the latest trends and priorities in the marketing landscape.
How Patient Services are redefining the patient relationship
The focus on a patient-first strategy suggests that even an "around the pill" strategy is not good enough.
The Cambridge Analytica Mess: What does it mean for Pharma?
Pharma marketing increasingly lives in a world of data. What happens in the world of Facebook cannot be ignored.
A New Pharma Renaissance? Three themes from JPM.
This year there was a palatable sense of renewed confidence. The latent fears of a fallow drug pipeline, patent cliffs, and an unstable insurance market seemed to be in the past.
The CVS & Aetna Merger - Four Key Observations
This merger will provide an environment for new business models to emerge and new ways healthcare will be practiced and delivered in the US.
Three lessons on effective marketing metrics
Find out how metrics reporting can help shape multichannel marketing decisions and investments.
Lessons on Leadership from the 2017 Race to Mackinac Island
What does a grueling 53-hour sailing race and the daily challenges of building a digital company have in common? Actually, quite a bit.
Value Extraction – Mining for Gold in Late-Stage Products
The long tail of data – techniques for turning old pharma products into productive assets
How to use data to capture value in pharma
During the commercialization phase, the purpose of data is to build trust. Trust and respect for the pharma brand are the ultimate benefits of data-enabled personalization and engagement, and are the leading qualitative indicators of acceptance and growth at launch.
Value creation powered by data
To be meaningful, pharma value must be about more than drug prices... value must be embedded in every aspect of the patient and provider experience.
Pharma's digital transformation should start with marketing
Digital allows pharma companies to quickly test and revise promotion tactics in the marketplace to create more wide-reaching and successful campaigns.
Content marketing and its impact on pharma
Physicians and patients are skeptical of purely promotional content. This leads to an opportunity to build trust and differentiation through unbranded content.
The hackathon model and its promise for pharma marketing
Pharma digital marketing: Will it scale?
The piloting of digital tools in pharma marketing, operations and R&D has been pervasive. But full implementation of digital in pharma marketing hasn’t happened yet.
What’s the difference between customer insight and customer intelligence?
Knowing the different between insight and decision-support is important when setting expectations with internal teams and with external agencies.
Filling the digital gap for pharma
Whenever there is a major paradigm shift in business, there is both a capability and a capacity gap. Rarely do companies have the right people, and enough of them, to fulfill the demands of a new business environment.
Four unique strategies for data in pharma
A significant share of our business focuses on data. We build and manage marketing data analytics and reporting platforms for pharmaceutical brand leaders.
Three questions data should answer for successful pharma marketing
At the heart of the matter, all this activity focuses on answering three basic questions about our healthcare audience: Who cares? What do they care about? And when do they need to know?
Pharma marketing: The heart of software and the face of services
Is the future of digital marketing primarily services or software? That is of course an overly simplistic question, but it’s one I think about frequently.
Building a master data vortex for pharma
What is needed today is continuous monitoring of our market and our customers and comprehensive reporting across every customer touch point. And to do that, we need a single centralized master database.
Marketing technology for pharma
An overview of some of today’s most talked about tech
The impact of pricing in healthcare - Striking a balance
Even as evidence grows that we have begun to bend the U.S. healthcare cost curve and reduce the inexorable rise in national healthcare expenses, there is a lot of talk about pricing, particularly pharmaceutical pricing.
What's your next move?
Get ahead of the current shift in pharma marketing by promoting not just the product, but patient outcomes.
Is there substance behind your style?
iPads alone cannot complete your closed-loop strategy.
Consumer health innovation and the window of opportunity for pharma
Learn more about how the pharma industry can play an important role in the next wave of digital health tools.
Make every move count
Approach physician marketing from a CRM perspective.
Are you seeing the whole picture?
Gain insight and clarity through physician CRM.
The drugs, Optistavin, Easovartis and Librylin, and names, results, case studies and specific information, referenced in this advertisement are fictional and were created solely for illustrating the digital marketing capabilities of closerlook, inc. Any resemblance to actual drugs, medications, treatments, persons, living or dead, or to actual events, is purely coincidental. closerlook, inc. does not assume and hereby disclaims any liability to any party for any loss, damage or disruption caused by such party’s reliance on the fictitious information contained in this illustration.